| This week's sponsor is Premier Research. | | | Rare Cancer Drug Research: What to Know Going In
Rare cancer drug research requires oncology and rare disease expertise and careful attention to trial design and regulatory demands. Get started with our white paper. Premier Research. It's what we do. Best. |
Today's Rundown IPO bonanza continues with $150M listing for CAR-T player Autolus Nanobiotix soars as late-phase cancer trial hits endpoint James Sabry takes over global partnering for Roche [Sponsored] Using technology to reduce cost, increase efficiency and mitigate clinical trial risk 'Big data' analysis links herpes virus to Alzheimer's development FDA expands use of Medtronic’s ‘artificial pancreas,’ approves Eversense’s implantable CGM system EuroBiotech Report—Freeline and iTeos lead big week for EU VC rounds, Calliditas, Evotec-Sanofi and Molecular Partners FiercePharmaAsia—China’s first I-O nod, Dr. Reddy’s Suboxone generic, MNC-to-biotech shifts Chutes & Ladders—Sanofi recruits French auto executive to replace outgoing CFO Featured Story | | | Friday, June 22, 2018 Biotech IPOs continue to come thick and fast this week, with U.K. T-cell therapy specialist Autolus the latest to list with an impressive $150 million raise. |
|
|
| This week's sponsor is Catalent. | | | |
Top Stories Friday, June 22, 2018 A phase 2/3 trial of Nanobiotix’s NBTXR3 in soft tissue sarcoma has met its primary endpoint. The top-line success against the pathological complete response rate endpoint sent Nanobiotix’s stock up by more than 50%. Friday, June 22, 2018 Roche has taken care to keep its pharma R&D group distinct from Genentech's since it acquired the biotech in 2008. In a reversal, the company is combining their partnering operations. Monday, June 18, 2018 This informative eBook explores technology currently being used to improve clinical trial efficiency, while also offering a peek into the emerging technologies that will shape the future success of clinical trials. Thursday, June 21, 2018 A "multi-omic" analysis of more than 900 donor brains linked the amount of herpes virus in a person's brain to the presence of Alzheimer's markers. The discovery opens up new avenues for Alzheimer's treatment and diagnosis, including antiviral drugs and virus-related biomarkers. Friday, June 22, 2018 In a double boost for patients with diabetes, the FDA signed off on expanding the use of Medtronic’s hybrid closed-loop insulin pump system to include patients between the ages of 7 to 13 with Type 1 diabetes and approved the Eversense continuous glucose monitoring system for patients 18 and older. Thursday, June 21, 2018 In this week's EuroBiotech Report, Freeline and iTeos reel in big rounds, Calliditas files for a $75 million IPO, Evotec snags Sanofi unit and more. Friday, June 22, 2018 Opdivo becomes the first cancer immunotherapy approved in China, with rivals close behind; Dr. Reddy’s halts its Suboxone Film generic rollout amid a patent dispute; many former Big Pharma executives have recently jumped to Chinese startups; and more. Friday, June 22, 2018 Sanofi recruits a French auto executive to replace its CFO, Molecular Partners brings on a Regeneron cancer leader, analyst Eric Schmidt moves to biotech at Allogene, and GlaxoSmithKline's head of dermatology joins Aclaris. These moves, plus more hirings, firings and retirings throughout the industry. Enrollment Showcase | | | Sponsored by: Bioinformatics at UTHealth SBMI UTHealth SBMI now offers a M.S. track in clinical and translational bioinformatics. |
|
|
Resources Life Science Strategy Group Take this anonymous 10-minute survey to share your thoughts on leading eClinical technology solutions and earn up to $55 honoraria. Take the survey now! Sponsored by: Blue Latitude Health Blue Latitude Health explores the commercial barriers and new stakeholder connections for pharma companies developing precision medicines, and reveals how to grasp novel opportunities in the new era of healthcare. Presented By: Covance A solid RBM plan will not only help you comply with the ICH guidelines, but will help you mitigate risks which could ultimately delay your trials and increase costs. Download today! Presented by: Patheon, part of Thermo Fisher Scientific “Faster and better” has become the mantra for biopharmaceutical companies as they face intense pressure to get therapies to market faster. Quickly proving efficacy in first-in-human (FIH) trials is a make-or-break milestone for these cash-strapped companies whose hopes hinge upon one or two molecules. Read how CDMOs are responding to this pressure. Sponsored by: Seton Hall Law 4-day interactive educational program trusted by multi-national companies as part of their compliance training for employees. Explore legal, regulatory and ethical issues faced by pharmaceutical, biotech and medical device manufacturers operating globally. Visit event homepage for session topics. Sponsored by: Docusign Life science companies are experiencing a significant transformation in how they bring new products to market. Drug Approval, Manufacturing Quality & Regulation 2018 | Online Innovation, Collaboration and Entrepreneurship in Drug Discovery June 28, 2018 | Cambridge, UK Sensors Expo & Conference Conference & Expo: June 26-28, 2018 | Pre-Conference Symposia: June 25, 2018 | San Jose, CA RESI HealthTech Week September 5-7, 2018 | Boston, MA The 16th Annual Discovery on Target September 25-28, 2018 | Boston, MA FierceBiotech 3rd Drug Development Forum October 1–3, 2018 | Hilton Boston Logan Airport Hotel | Boston, MA 10th International Leaders in Biobanking Congress October 14-16, 2018 | Cleveland, OH Drug Development Boot Camp® 2018 – Register Now! November 14-15, 2018 | Boston, MA | Register now and start your pre-Boot Camp preparation |
